当前位置:首页 - 行情中心 - 康华生物(300841) - 财务分析 - 现金流量表

康华生物

(300841)

  

流通市值:90.97亿  总市值:99.40亿
流通股本:1.19亿   总股本:1.30亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金863,856,151.93526,814,912.41225,520,921.411,467,587,183.32
  收到的税费返还66,30066,30066,300-
  收到其他与经营活动有关的现金10,429,261.136,343,830.743,828,822.52148,444,999.94
  经营活动现金流入小计874,351,713.06533,225,043.15229,416,043.931,616,032,183.26
  购买商品、接受劳务支付的现金28,640,735.2618,146,079.177,827,935.5828,884,364.52
  支付给职工以及为职工支付的现金127,322,820.2493,551,440.6558,798,609.14171,731,678.8
  支付的各项税费54,708,308.7434,243,166.6921,160,620.48144,179,569.87
  支付其他与经营活动有关的现金509,954,643.94321,961,868.92158,315,312.7698,994,672.59
  经营活动现金流出小计720,626,508.18467,902,555.43246,102,477.91,043,790,285.78
  经营活动产生的现金流量净额153,725,204.8865,322,487.72-16,686,433.97572,241,897.48
二、投资活动产生的现金流量:
  收回投资收到的现金515,768,711.84260,000,000260,000,000101,118,172.16
  取得投资收益收到的现金4,602,005116,367.66116,367.661,037,915.78
  处置固定资产、无形资产和其他长期资产收回的现金净额17,50017,500-276,538.76
  投资活动现金流入小计520,388,216.84260,133,867.66260,116,367.66102,432,626.7
  购建固定资产、无形资产和其他长期资产支付的现金48,071,836.0733,586,357.5121,760,357.62144,299,477.28
  投资支付的现金560,000,000310,000,000310,000,000300,000,000
  投资活动现金流出小计608,071,836.07343,586,357.51331,760,357.62444,299,477.28
  投资活动产生的现金流量净额-87,683,619.23-83,452,489.85-71,643,989.96-341,866,850.58
三、筹资活动产生的现金流量:
  取得借款收到的现金149,793,800139,793,80059,793,800237,784,905.68
  筹资活动现金流入小计149,793,800139,793,80059,793,800237,784,905.68
  偿还债务支付的现金186,784,905.68175,344,705.6885,344,705.68241,754,880.79
  分配股利、利润或偿付利息支付的现金135,686,621.95134,881,273.33,946,997.55267,827,351.09
  支付其他与筹资活动有关的现金---199,997,626.19
  筹资活动现金流出小计322,471,527.63310,225,978.9889,291,703.23709,579,858.07
  筹资活动产生的现金流量净额-172,677,727.63-170,432,178.98-29,497,903.23-471,794,952.39
四、汇率变动对现金及现金等价物的影响55,411.662,092.3664,558.691,767,174.7
五、现金及现金等价物净增加额-106,580,730.38-188,500,088.75-117,763,768.47-239,652,730.79
  加:期初现金及现金等价物余额799,713,290.37799,713,290.37799,713,290.371,039,366,021.16
  期末现金及现金等价物余额693,132,559.99611,213,201.62681,949,521.9799,713,290.37
补充资料:
  净利润-114,520,580.49-398,651,923.09
  资产减值准备-13,767,204.48-1,629,924.78
  固定资产和投资性房地产折旧-35,774,633.66-62,649,317.54
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-35,774,633.66-62,649,317.54
  无形资产摊销-1,953,953.39-2,583,033.16
  长期待摊费用摊销-4,368,042.76-9,461,538.23
  处置固定资产、无形资产和其他长期资产的损失-8,912.45-1,794,548.96
  固定资产报废损失-34,737.67-15,389.82
  公允价值变动损失--1,897,619.2-59,726,140.81
  财务费用-1,981,355.06-3,608,547.41
  投资损失--109,780.81--891,245.73
  递延所得税--1,053,860.11--4,572,854.9
  其中:递延所得税资产减少--1,053,860.11--2,073,188.56
    递延所得税负债增加----2,499,666.34
  存货的减少--2,385,947.8--4,975,741.53
  经营性应收项目的减少-23,450,282.53-102,447,246.83
  经营性应付项目的增加--125,090,006.85--90,028,093.9
  现金的期末余额-611,213,201.62-799,713,290.37
  减:现金的期初余额-799,713,290.37-1,039,366,021.16
  现金及现金等价物的净增加额--188,500,088.75--239,652,730.79
公告日期2025-10-172025-08-262025-04-192025-04-19
审计意见(境内)标准无保留意见
TOP↑